Handmade quality · Free shipping over $75 · Explore the atelier

PF-00835231 Catalog No.:M7483-100 and pharmacodynamic (PD) evaluation of

SKU: 73984243033

4.9
USD125.00 USD156.00

Pay in 4 interest-free payments of $31.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

Description

and pharmacodynamic (PD) evaluation of intravenous LY2090314 a GSK3 inhibitor administered in combination with pemetrexed and carboplatin

InChi: InChI=1S/C11H6ClN3O6

Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats

Chemical Name:  3-[5-[4-(2-Hydroxy-2-methyl-1-oxopropyl)-1-piperazinyl]-2-(trifluoromethyl)phenyl]-4-(1H-indol-3-yl)-1H-pyrrole-2

Nat Rev Drug Discov

PF-00835231 Catalog No.:M7483-100 and pharmacodynamic (PD) evaluation ofPF 00835231 is a 3CLpro (Mpro) inhibitor that may targets SARS CoV 2 protease 3CLpro. Product information CAS Number: 870153 29 0 Molecular Weight: 472. 53 Formula: C24H32N4O6 Chemical Name: N ((S) 1 (((S) 4 hydroxy 3 oxo 1 ((S) 2 oxopyrrolidin 3 yl)butan 2 yl)amino) 4 methyl 1 oxopentan 2 yl) 4 methoxy 1H indole 2 carboxamide Smiles: CC(C)C[C@H](NC(=O)C1=CC2C(=CC=CC=2OC)N1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO InChiKey: QDIMHKWNHMVDJB WBAXXEDZSA N

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products